Options: Show MedDRA Preferred Terms, display all 28 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Absence congenital | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||
| Atrophy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Dysfunction thyroid | x | x | ||||||||||||||||||||
| Follicular thyroid cancer | x | x | ||||||||||||||||||||
| Goitre | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Hashimoto's disease | x | x | x | x | x | x | ||||||||||||||||
| Hypothyroidism | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Myxoedema coma | x | |||||||||||||||||||||
| Neoplasm malignant | x | x | x | x | x | x | x | |||||||||||||||
| Primary hypothyroidism | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Subclinical hypothyroidism | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Thyroid nodule | x | x | x | x | x | x | x | x | ||||||||||||||
| Thyroiditis | x | x | ||||||||||||||||||||
| Thyroiditis subacute | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |